GE HealthCare (GEHC) has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the European CE Mark for its image-guided platform Allia Moveo. GEHC unveiled the platform at RSNA 2025.
GE HealthCare's Allia Moveo.GEHC
The interventional procedures platform consists of a cable-free C-arm system and includes AI tools such as CleaRecon DL, which removes streak artifacts caused by blood flow in the arteries; Motion Freeze, which offsets involuntary respiratory motion artifacts to improve image clarity; and Metallic Artifact Reduction, which reveals anatomic details obscured by metal artifacts.
Allia Moveo has been installed at Hôpital Marie-Lannelongue in Le Plessis-Robinson, France, GEHC said.
